Abstract
Introduction: Comorbid attention deficit/hyperactivity disorder (ADHD) is present in 15–25% of all patients seeking treatment for substance use disorders (SUDs). Some studies suggest that comorbid ADHD increases clinical severity related to SUDs, other psychiatric comorbidities, and social impairment, but could not disentangle their respective influences. Objectives: To investigate whether comorbid adult ADHD in treatment-seeking SUD patients is associated with more severe clinical profiles in these domains assessed altogether. Methods: Treatment-seeking SUD patients from 8 countries (N = 1,294: 26% females, mean age 40 years [SD = 11 years]) were assessed for their history of DSM-IV ADHD, SUDs, and other psychiatric conditions and sociodemographic data. SUD patients with and without comorbid ADHD were compared on indicators of severity across 3 domains: addiction (number of SUD criteria and diagnoses), psychopathological complexity (mood disorders, borderline personality disorder, lifetime suicidal thoughts, or behavior), and social status (education level, occupational and marital status, and living arrangements). Regression models were built to account for confounders for each severity indicator. Results: Adult ADHD was present in 19% of the SUD patients. It was significantly associated with higher SUD severity, more frequent comorbid mood or borderline personality disorder, and less frequent “married” or “divorced” status, as compared with the absence of comorbid ADHD. ADHD comorbidity was independently associated with a higher number of dependence diagnoses (OR = 1.97) and more psychopathology (OR = 1.5), but not marital status. Conclusions: In treatment-seeking SUD patients, comorbid ADHD is associated with polysubstance dependence, psychopathological complexity, and social risks, which substantiates the clinical relevance of screening, diagnosing, and treating ADHD in patients with SUDs.
References
1.
Degenhardt
L
, Hall
W
. Extent of illicit drug use and dependence, and their contribution to the global burden of disease
. Lancet
. 2012 Jan 7
;379
(9810
):55
–70
. 2.
Iqbal
MN
, Levin
CJ
, Levin
FR
. Treatment for substance use disorder with co-occurring mental illness
. Focus
. 2019 Apr 1
;17
(2
):88
–97
. 3.
van Emmerik-van Oortmerssen
K
, van de Glind
G
, van den Brink
W
, Smit
F
, Crunelle
CL
, Swets
M
, et al Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis
. Drug Alcohol Depend
. 2012 Apr 1
;122
(1–2
):11
–9
. 4.
Breyer
JL
, Lee
S
, Winters
KC
, August
GJ
, Realmuto
GM
. A longitudinal study of childhood ADHD and substance dependence disorders in early adulthood
. Psychol Addict Behav
. 2014 Mar
;28
(1
):238
–46
. 5.
Fatséas
M
, Hurmic
H
, Serre
F
, Debrabant
R
, Daulouède
JP
, Denis
C
, et al Addiction severity pattern associated with adult and childhood attention deficit hyperactivity disorder (ADHD) in patients with addictions
. Psychiatry Res
. 2016 Dec 30
;246
:656
–62
. 6.
Moura
HF
, Faller
S
, Benzano
D
, Szobot
C
, von Diemen
L
, Stolf
AR
, et al The effects of ADHD in adult substance abusers
. J Addict Dis
. 2013
;32
(3
):252
–62
. 7.
Wilens
TE
, Biederman
J
, Mick
E
. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD
. Am J Addict
. 1998
;7
(2
):156
–63
. 8.
Dunne
EM
, Hearn
LE
, Rose
JJ
, Latimer
WW
. ADHD as a risk factor for early onset and heightened adult problem severity of illicit substance use: an accelerated gateway model
. Addict Behav
. 2014 Dec 1
;39
(12
):1755
–8
. 9.
Wilens
TE
, Upadhyaya
HP
. Impact of substance use disorder on ADHD and its treatment
. J Clin Psychiatry
. 2007 Aug
;68
(8
):e20
. 10.
Crunelle
CL
, van den Brink
W
, Moggi
F
, Konstenius
M
, Franck
J
, Levin
FR
, et al International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder
. Eur Addict Res
. 2018
;24
(1
):43
–51
. 11.
Sibley
MH
, Rohde
LA
, Swanson
JM
, Hechtman
LT
, Molina
BSG
, Mitchell
JT
, et al Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25
. Am J Psychiatry
. 2018
;175
(2
):140
–9
. 12.
Oortmerssen
KE
, Glind
Gd
, Koeter
MWJ
, Allsop
S
, Auriacombe
M
, Barta
C
, et al Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study
. Addiction
. 2014
;109
(2
):262
–72
.13.
Carpentier
PJ
, van Gogh
MT
, Knapen
LJM
, Buitelaar
JK
, De Jong
CAJ
. Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients
. Eur Addict Res
. 2011
;17
(1
):10
–20
. 14.
Yuodelis‐Flores
C
, Ries
RK
. Addiction and suicide: a review
. Am J Addict
. 2015
;24
(2
):98
–104
.15.
Icick
R
, Vorspan
F
, Karsinti
E
, Ksouda
K
, Lépine
JP
, Brousse
G
, et al Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders
. J Affect Disord
. 2018 Dec 1
;241
:546
–53
. 16.
Darke
S
, Ross
J
. Suicide among heroin users: rates, risk factors and methods
. Addiction
. 2002 Nov
;97
(11
):1383
–94
. 17.
Rosen
PJ
, Factor
PI
. Emotional impulsivity and emotional and behavioral difficulties among children with ADHD: an ecological momentary assessment study
. J Atten Disord
. 2015 Sep
;19
(9
):779
–93
. 18.
Baer
MM
, LaCroix
JM
, Browne
JC
, Hassen
HO
, Perera
KU
, Soumoff
A
, et al Impulse control difficulties while distressed: a facet of emotion dysregulation links to non-suicidal self-injury among psychiatric inpatients at military treatment facilities
. Psychiatry Res
. 2018
;269
:419
–24
. 19.
Impey
M
, Heun
R
. Completed suicide, ideation and attempt in attention deficit hyperactivity disorder
. Acta Psychiatr Scand
. 2012 Feb
;125
(2
):93
–102
. 20.
Kessler
RC
, Foster
CL
, Saunders
WB
, Stang
PE
. Social consequences of psychiatric disorders, I: educational attainment
. Am J Psychiatry
. 1995 Jul
;152
(7
):1026
–32
. 21.
Kessler
RC
, Berglund
PA
, Foster
CL
, Saunders
WB
, Stang
PE
, Walters
EE
. Social consequences of psychiatric disorders, II: teenage parenthood
. Am J Psychiatry
. 1997 Oct
;154
(10
):1405
–11
. 22.
Kessler
RC
, Walters
EE
, Forthofer
MS
. The social consequences of psychiatric disorders, III: probability of marital stability
. Am J Psychiatry
. 1998 Aug
;155
(8
):1092
–6
. 23.
Erskine
HE
, Norman
RE
, Ferrari
AJ
, Chan
GC
, Copeland
WE
, Whiteford
HA
, et al Long-term outcomes of attention-deficit/hyperactivity disorder and conduct disorder: a systematic review and meta-analysis
. J Am Acad Child Adolesc Psychiatry
. 2016
;55
(10
):841
–50
. 24.
Colpaert
K
, De Maeyer
J
, Broekaert
E
, Vanderplasschen
W
. Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment
. Eur Addict Res
. 2013
;19
(4
):173
–83
. 25.
van de Glind
G
, Van Emmerik-van Oortmerssen
K
, Carpentier
PJ
, Levin
FR
, Koeter
MW
, Barta
C
, et al The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population
. Int J Methods Psychiatr Res
. 2013 Sep
;22
(3
):232
–44
. 26.
Epstein
JN
, Kollins
SH
. Psychometric properties of an adult ADHD diagnostic interview
. J Atten Disord
. 2006 Feb
;9
(3
):504
–14
. 27.
Kessler
RC
, Adler
L
, Ames
M
, Demler
O
, Faraone
S
, Hiripi
E
, et al The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population
. Psychol Med
. 2005 Feb
;35
(2
):245
–56
. 28.
Sheehan
DV
, Lecrubier
Y
, Sheehan
KH
, Amorim
P
, Janavs
J
, Weiller
E
, et al The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
. J Clin Psychiatry
. 1998
;59
(Suppl 20
):22
–57
.29.
Mestre-Pintó
JI
, Domingo-Salvany
A
, Martín-Santos
R
, Torrens
M
; PsyCoBarcelona Group
. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument
. Eur Addict Res
. 2014
;20
(1
):41
–8
. 30.
Kranzler
HR
, Kadden
RM
, Babor
TF
, Tennen
H
, Rounsaville
BJ
. Validity of the SCID in substance abuse patients
. Addiction
. 1996 Jun
;91
(6
):859
–68
. 31.
Icick
R
, Peoc’h
K
, Karsinti
E
, Ksouda
K
, Hajj
A
, Bloch
V
, et al A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients
. Am J Addict
. 2015 Oct
;24
(7
):613
–20
. 32.
First
M
. Structured Clinical Interview for DSM-IV Axis I Disorders
. Washington, DC
: American Psychiatric Press
; 1997
.33.
Weiss
RD
, Najavits
LM
, Muenz
LR
, Hufford
C
. Twelve-month test-retest reliability of the structured clinical interview for DSM-III-R personality disorders in cocaine-dependent patients
. Compr Psychiatry
. 1995 Sep 1
;36
(5
):384
–9
. 34.
Becker
JB
, Chartoff
E
. Sex differences in neural mechanisms mediating reward and addiction
. Neuropsychopharmacology
. 2019
;44
(1
):166
–83
. 35.
Fedele
DA
, Lefler
EK
, Hartung
CM
, Canu
WH
. Sex differences in the manifestation of ADHD in emerging adults
. J Atten Disord
. 2012 Feb
;16
(2
):109
–17
. 36.
Zilberman
ML
, Tavares
H
, Blume
SB
, el-Guebaly
N
. Substance use disorders: sex differences and psychiatric comorbidities
. Can J Psychiatry
. 2003 Feb
;48
(1
):5
–13
. 37.
van de Glind
G
, Konstenius
M
, Koeter
MWJ
, van Emmerik-van Oortmerssen
K
, Carpentier
PJ
, Kaye
S
, et al Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria
. Drug Alcohol Depend
. 2014 Jan 1
;134
:158
–66
. 38.
R Core Team. R
. A language and environment for statistical computing
[Internet]
. Vienna, Austria
: R Foundation for Statistical Computing
; 2019
. Available from: https://www.R-project.org/
.39.
R Studio Team. R Studio. 2019
.40.
Evans
EA
, Grella
CE
, Washington
DL
, Upchurch
DM
. Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders
. Drug Alcohol Depend
. 2017 01
;174
:128
–36
. 41.
Groß-Lesch
S
, Dempfle
A
, Reichert
S
, Jans
T
, Geissler
J
, Kittel-Schneider
S
, et al Sex- and subtype-related differences in the comorbidity of adult ADHDs
. J Atten Disord
. 2016 Oct 1
;20
(10
):855
–66
. 42.
Grant
BF
, Saha
TD
, Ruan
WJ
, Goldstein
RB
, Chou
SP
, Jung
J
, et al Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III
. JAMA Psychiatry
. 2016 Jan 1
;73
(1
):39
–47
. 43.
Zlotnick
C
, Clarke
JG
, Friedmann
PD
, Roberts
MB
, Sacks
S
, Melnick
G
. Gender differences in comorbid disorders among offenders in prison substance abuse treatment programs
. Behav Sci Law
. 2008
;26
(4
):403
–12
. 44.
Barral
C
, Daigre
C
, Bachiller
D
, Calvo
N
, Ros-Cucurull
E
, Gancedo
B
, et al Severity factors associated with borderline personality disorder among misusers in an outpatient sample in Spain
. J Addict Dis
. 2017 Jun
;36
(2
):93
–6
. 45.
Laudet
AB
. Rate and predictors of employment among formerly polysubstance dependent urban individuals in recovery
. J Addict Dis
. 2012
;31
(3
):288
–302
. 46.
Heinz
AJ
, Wu
J
, Witkiewitz
K
, Epstein
DH
, Preston
KL
. Marriage and relationship closeness as predictors of cocaine and heroin use
. Addict Behav
. 2009 Mar
;34
(3
):258
–63
. 47.
Leonard
KE
, Rothbard
JC
. Alcohol and the marriage effect
. J Stud Alcohol Suppl
. 1999 Mar
;13
:139
–46
. 48.
Kessler
RC
, Adler
L
, Barkley
R
, Biederman
J
, Conners
CK
, Demler
O
, et al The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication
. Am J Psychiatry
. 2006 Apr
;163
(4
):716
–23
. 49.
Upadhyaya
HP
, Carpenter
MJ
. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use?
Am J Addict
. 2008 Jun
;17
(3
):195
–8
. 50.
Swanson
JM
, Schuck
S
, Porter
MM
, Carlson
C
, Hartman
CA
, Sergeant
JA
, et al Categorical and dimensional definitions and evaluations of symptoms of ADHD: history of the SNAP and the SWAN Rating Scales
. Int J Educ Psychol Assess
. 2012 Apr
;10
(1
):51
–70
.51.
Anker
E
, Halmøy
A
, Heir
T
. Work participation in ADHD and associations with social characteristics, education, lifetime depression, and ADHD symptom severity
. Atten Defic Hyperact Disord
. 2019 Jun
;11
(2
):159
–65
. 52.
Konstenius
M
, Leifman
A
, van Emmerik-van Oortmerssen
K
, van de Glind
G
, Franck
J
, Moggi
F
, et al Childhood trauma exposure in substance use disorder patients with and without ADHD
. Addict Behav
. 2017
;65
:118
–24
. 53.
Miranda
A
, Colomer
C
, Berenguer
C
, Roselló
R
, Roselló
B
. Substance use in young adults with ADHD: comorbidity and symptoms of inattention and hyperactivity/impulsivity
. Int J Clin Health Psychol
. 2016 Aug
;16
(2
):157
–65
. 54.
Matthys
F
, Bronckaerts
A
, Crunelle
CL
. Managing ADHD in the presence of substance use disorders
. Oud-Turnhout, Belgium
: Gompel&Svacina
; 2018
; p. 162
.55.
Skoglund
C
, Brandt
L
, D’Onofrio
B
, Larsson
H
, Franck
J
. Methylphenidate doses in attention deficit/hyperactivity disorder and comorbid substance use disorders
. Eur Neuropsychopharmacol
. 2017 Nov 1
;27
(11
):1144
–52
. 56.
Perugi
G
, Pallucchini
A
, Rizzato
S
, De Rossi
P
, Sani
G
, Maremmani
AG
, et al Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD)
. Expert Opin Pharmacother
. 2019 Feb 11
;20
(3
):343
–55
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
